Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Veru Inc. (VERU)

  • Technical Exchange News
  • Feb. 01, 2024, 18:57 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Sonnet BioTherapeutics Holdings Inc. (SONN)

  • Technical Exchange News
  • Feb. 01, 2024, 18:57 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Purple Biotech Ltd. (PPBT)

  • Technical Exchange News
  • Feb. 01, 2024, 18:56 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Veru Inc. (VERU)

  • Technical Exchange News
  • Feb. 01, 2024, 18:44 UTC
  • 43
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Sonnet BioTherapeutics Holdings Inc. (SONN)

  • Technical Exchange News
  • Feb. 01, 2024, 18:44 UTC
  • 42
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Purple Biotech Ltd. (PPBT)

  • Technical Exchange News
  • Feb. 01, 2024, 18:44 UTC
  • 43
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Zentalis Pharmaceuticals (ZNTL)

  • Technical Exchange News
  • Jan. 31, 2024, 21:05 UTC
  • 43
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Phio Pharmaceuticals Corp. (PHIO)

  • Technical Exchange News
  • Jan. 31, 2024, 21:02 UTC
  • 41
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Zentalis Pharmaceuticals (ZNTL)

  • Technical Exchange News
  • Jan. 31, 2024, 21:01 UTC
  • 40
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Phio Pharmaceuticals Corp. (PHIO)

  • Technical Exchange News
  • Jan. 31, 2024, 21:01 UTC
  • 39
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 1051
  • 1052
  • 1053
  • 1054
  • 1055
  • Next

Search

News categories

  • Technical Exchange News(14604)
  • Event(6229)
  • SEC News(385338)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(235182)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin